Gold Prices Face Potential Headwinds from Peace Talks and Rate Hike Concerns Bitcoin Dips Below 76000 Poised for Weekly Decline Amid Liquidations and Rate Volatility UK Secures 37bn Trade Agreement with Six Gulf States Slashing 580m in Tariffs Love Factually Dating Startups Target Fake Profiles with Verified Identity Solutions SK Hynix Surpasses 1 Trillion Valuation as AI Demand Drives South Korean Chip Stocks Higher SpaceX Reportedly Files S1 Registration Statement Signaling Potential IPO Atrium Therapeutics Inc RNA Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment HEI Q4 2025 Earnings EPS Beats Estimates Amid Mixed Market Signal ELVA Q1 2026 Earnings EPS Surges Past Estimates with 307 Beat TSSI Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Remains Undisclosed MBINN Q1 2026 Earnings EPS Surpasses Estimates with 502 Surprise Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue Thornburg Income Builder Opportunities Trust TBLD Gains 22 as IncomeFocused Funds Find Favor Columbus Circle Capital Corp II CMII Holds Steady at 991 as Market Watches Key Levels Gyrodyne LLC GYRO Holds Steady at 711 as Support and Resistance Levels Define Trading Range CMS Energy Preferreds CMSD Edge Higher Amid Stable Yield Environment ALX Oncology Slips 15 as Biotech Stock Tests Key Support at 183 Huawei Unveils New Chip Design Approach Plans Fall Smartphone Chips Amid US Restrictions and Rivalry with Nvidia Apple Tetra Technologies TTI Q1 2026 Earnings EPS Beat Drives 81 Surprise Amid Revenue Disclosures Lacking Cantor Equity Partners III CAEP Holds Steady at 150 as Support and Resistance Levels Tighten Ekso Bionics EKSO Climbs 129 as Stock Tests Key Resistance Level Bolt Biotherapeutics BOLT Edges Higher Amid Tight Trading Range Support and Resistance Levels in Focus Nayax Ltd NYAX Climbs 417 as Bullish Tone Emerges Erasca Inc ERAS Edges Higher Toward Resistance as Biotech Sector Watches OneSpaWorld OSW Edges Higher Amid Steady Trading Resistance Test in Focus Acurx Pharmaceuticals ACXP Nudges Higher as Stock Approaches Resistance Provident Financial Services PFS Advances 17 as It Approaches Key Resistance